Results 101 to 110 of about 90,437 (193)

Endothelial keratoplasty combined with scleral fixation intraocular lens [PDF]

open access: yesInternational Journal of Ophthalmology, 2021
Mariantonia Ferrara   +4 more
doaj   +1 more source

Multimodal diagnostics for keratoconus and ectatic corneal diseases: a paradigm shift. [PDF]

open access: yesEye Vis (Lond), 2023
Ambrósio R   +9 more
europepmc   +1 more source

Central Corneal Thickness and Glaucoma Risk: The Importance of Corneal Pachymetry in Screening Adults Over 50 and Glaucoma Suspects

open access: yes
David Agbato,1 Kara Rickford,2 Daniel Laroche3,4 1CUNY School of Medicine, The City College of New York, New York, NY, USA; 2School of Medicine, New York Medical College, Valhalla, NY, USA; 3Department of Ophthalmology, New York Eye and Ear Infirmary of ...
Agbato D, Rickford K, Laroche D
core  

Keratoconus; a true corneal disease

open access: yesJournal of Ophthalmic and Vision Research, 2016
Navid Ghassembaglou, Ali R Djalilian
openaire   +3 more sources

Corneal Biomechanical Changes in Patients with Inherited Retinal Diseases

open access: yes
Ana Marta,1,2 André Ferreira,1,3,4 Inês Couto,1 Miguel Mesquita Neves,1 Miguel Gomes,1 Luis Oliveira,1 Celia Azevedo Soares,5– 8 Maria João Menéres,1,2 Carolina Lemos,2,8 João Melo Beirão1,2 1Department of Ophthalmology, Centro Hospitalar Universitário ...
Oliveira L   +9 more
core  

Editorial: Corneal disease: an update

open access: yesFrontiers in Medicine, 2023
Luigi Capasso   +3 more
openaire   +3 more sources

Evaluation of a computer-aided diagnostic model for corneal diseases by analyzing in vivo confocal microscopy images. [PDF]

open access: yesFront Med (Lausanne), 2023
Yan Y   +22 more
europepmc   +1 more source

Persistent corneal epithelial defect responding to rebamipide ophthalmic solution in a patient with diabetes

open access: yes, 2016
Yusuke Hayashi, Hiroshi Toshida, Yusuke Matsuzaki, Asaki Matsui, Toshihiko Ohta Department of Ophthalmology, Juntendo University Shizuoka Hospital, Izunokuni, Shizuoka, Japan Objective: Rebamipide ophthalmic suspension was developed for the treatment of
Hayashi Y   +4 more
core  

Home - About - Disclaimer - Privacy